Avanos Medical Inc
AVNS11.275USD
+0.295+2.69%
Market hours （ET）Quotes delayed by 15 min
521.33MMarket Cap
LossP/E TTM
More Details of Avanos Medical Inc Company
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Company’s acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Company Info
Ticker SymbolAVNS
Company nameAvanos Medical Inc
IPO dateOct 21, 2014
CEOMr. David Pacitti
Number of employees2227
Security typeOrdinary Share
Fiscal year-endOct 21
Address5405 Windward Parkway
CityALPHARETTA
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code30004
Phone18444282667
Websitehttps://avanos.com/
Ticker SymbolAVNS
IPO dateOct 21, 2014
CEOMr. David Pacitti
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer
Chief Executive Officer
242.05K
--
Ms. Mojirade James
Ms. Mojirade James
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
132.93K
+13.98%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
71.59K
--
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Mr. Jason M. Pickett
Mr. Jason M. Pickett
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Kerr W. Holbrook
Mr. Kerr W. Holbrook
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
--
--
Ms. Indrani L. Franchini, J.D.
Ms. Indrani L. Franchini, J.D.
Independent Director
Independent Director
--
--
Dr. Lisa C. Egbuonu-Davis, M.D.
Dr. Lisa C. Egbuonu-Davis, M.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. David Pacitti
Mr. David Pacitti
Chief Executive Officer
Chief Executive Officer
242.05K
--
Ms. Mojirade James
Ms. Mojirade James
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
132.93K
+13.98%
Mr. Gary D. Blackford
Mr. Gary D. Blackford
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
71.59K
--
Mr. Patrick J. O'Leary
Mr. Patrick J. O'Leary
Independent Director
Independent Director
66.64K
--
Dr. Julie Ann Shimer, Ph.D.
Dr. Julie Ann Shimer, Ph.D.
Independent Director
Independent Director
62.09K
--
Mr. Sigfrido (Sig) Delgado
Mr. Sigfrido (Sig) Delgado
Senior Vice President - Integrated Supply Chain
Senior Vice President - Integrated Supply Chain
44.12K
+58.59%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Enteral feeding
74.50M
44.48%
Radiofrequency ablation
31.70M
18.93%
Neonate solutions
26.60M
15.88%
Surgical pain and recovery
24.50M
14.63%
Corporate & Other
10.20M
6.09%
By RegionUSD
Name
Revenue
Proportion
North America
130.80M
78.09%
Europe, Middle East and Africa
23.70M
14.15%
Asia Pacific and Latin America
13.00M
7.76%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Enteral feeding
74.50M
44.48%
Radiofrequency ablation
31.70M
18.93%
Neonate solutions
26.60M
15.88%
Surgical pain and recovery
24.50M
14.63%
Corporate & Other
10.20M
6.09%
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.84%
The Vanguard Group, Inc.
9.66%
T. Rowe Price Investment Management, Inc.
8.13%
Dimensional Fund Advisors, L.P.
5.61%
Armistice Capital LLC
4.32%
Other
58.44%
Shareholders
Shareholders
Proportion
BlackRock Institutional Trust Company, N.A.
13.84%
The Vanguard Group, Inc.
9.66%
T. Rowe Price Investment Management, Inc.
8.13%
Dimensional Fund Advisors, L.P.
5.61%
Armistice Capital LLC
4.32%
Other
58.44%
Shareholder Types
Shareholders
Proportion
Investment Advisor
49.49%
Investment Advisor/Hedge Fund
26.84%
Hedge Fund
12.65%
Individual Investor
3.85%
Research Firm
2.44%
Pension Fund
1.13%
Family Office
1.11%
Bank and Trust
0.48%
Sovereign Wealth Fund
0.41%
Other
1.60%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
602
45.07M
97.47%
-3.44M
2025Q1
625
45.60M
98.62%
-4.71M
2024Q4
608
45.85M
99.67%
-4.42M
2024Q3
597
45.57M
99.16%
-4.09M
2024Q2
599
45.09M
98.21%
-5.57M
2024Q1
607
46.20M
99.99%
-5.04M
2023Q4
613
46.52M
100.18%
-4.77M
2023Q3
611
46.28M
98.90%
-3.96M
2023Q2
610
46.69M
100.04%
-2.11M
2023Q1
634
46.30M
99.34%
-1.85M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BlackRock Institutional Trust Company, N.A.
6.40M
13.84%
-218.21K
-3.30%
Mar 31, 2025
The Vanguard Group, Inc.
5.29M
11.43%
-27.57K
-0.52%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
3.76M
8.13%
+746.26K
+24.78%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.60M
5.61%
+17.04K
+0.66%
Mar 31, 2025
Armistice Capital LLC
2.00M
4.32%
+2.00M
--
Mar 31, 2025
Brown Advisory
1.93M
4.18%
+26.07K
+1.37%
Mar 31, 2025
State Street Global Advisors (US)
1.93M
4.17%
-30.80K
-1.57%
Mar 31, 2025
Paradice Investment Management LLC
1.29M
2.78%
-7.17K
-0.55%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.09M
2.35%
+594.35K
+120.16%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.08M
2.33%
+35.44K
+3.40%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPDR S&P Health Care Equipment ETF
0.96%
Invesco S&P SmallCap 600 Pure Value ETF
0.53%
Invesco S&P SmallCap Health Care ETF
0.4%
Harbor Human Capital Factor US Small Cap ETF
0.34%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.28%
Royce Quant Small-Cap Quality Value ETF
0.26%
Vanguard US Value Factor ETF
0.17%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.15%
Pacer US Small Cap Cash Cows ETF
0.14%
Fidelity Enhanced Small Cap ETF
0.14%
View more
SPDR S&P Health Care Equipment ETF
Proportion0.96%
Invesco S&P SmallCap 600 Pure Value ETF
Proportion0.53%
Invesco S&P SmallCap Health Care ETF
Proportion0.4%
Harbor Human Capital Factor US Small Cap ETF
Proportion0.34%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proportion0.28%
Royce Quant Small-Cap Quality Value ETF
Proportion0.26%
Vanguard US Value Factor ETF
Proportion0.17%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proportion0.15%
Pacer US Small Cap Cash Cows ETF
Proportion0.14%
Fidelity Enhanced Small Cap ETF
Proportion0.14%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
